Find Faculty
Emma Guttman, MD, PhD
img_Emma Guttman
PROFESSOR AND SYSTEM CHAIR | Dermatology
PROFESSOR | Medicine, Clinical Immunology
email
Are you a patient?
View my
Provider Profile
Specialties
Dermatology
Multi-Disciplinary Training Area
Immunology [IMM]
Inflammatory Skin Diseases
Dr. Guttman’s groundbreaking research focuses on atopic dermatitis/eczema and contact dermatitis. Her research has important implications in advancing the current molecular knowledge on atopic dermatitis/eczema and developing new therapeutics. Dr. Guttman currently develops biomarkers of atopic dermatitis that could be used for future studies with targeted therapeutics. She also concentrates on unraveling the primary pathogenesis of this common disease. She is the recipient of the prestigious Young Investigator Award (2011) from the of Dermatology, the 2011 recipient of the Dermatology Foundation’s Physician-Scientist Career Development Award, and the recipient of the Fisher award of the American Contact Dermatitis Society 2011.

MD, Tel-Aviv University Sackler School Of Medicine

Residency, Dermatology, Rambam Medical Center/Technion

Internship, Internal Medicine, Memorial Sloan-Kettering Cancer Center

Residency, Dermatology, Weill Cornell Medical College-New York Hospital

2022

Keynote Lecture: Atopic Dermatitis: The Road to a Personalized Medicine Approach, the 51st ESDR Annual Meeting

European Society for Dermatological Research (ESDR)

2021

Donald Y. M. Leung, MD, PhD, the JACI Editors’ Lectureship and Faculty Development Award, the 2021 AAAAI Virtual Annual Meeting

American Academy of Allergy, Asthma & Immunology (AAAAI)

2021

Article of the Year Award: “Transcriptomic Profiling of Tape-Strips from Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab”

American Contact Dermatitis Society (ACDS) Editorial/Publications Committee

2019

Bettina C. Hilman, MD Lectureship and Award

American Academy of Allergy and Immunology (AAAAI)

2019

Elected as one of 4 international organizers (two from US and two from EU) of the 2nd Keystone Symposia on Skin Health and Disease: Immune, Microbiome and Epithelia crosstalk

Keystone Symposia

2018

Hugh A. Sampson Lectureship and Award

American Academy of Allergy and Immunology (AAAAI)

2018

President, International Eczema Council

International Eczema Council

2018

Elected to the board of the American Skin Association (ASA)

American Skin Association (ASA)

2011

Young Investigator Award (2011)

American Academy of Dermatology

361
Publications

Selected Publications

Age of onset defines two distinct profiles of atopic dermatitis in adults. Paola Facheris, Joel Correa Da Rosa, Angel D. Pagan, Michael Angelov, Ester Del Duca, Grace Rabinowitz, Pedro Jesús Gómez-Arias, Camille Rothenberg-Lausell, Yeriel D. Estrada, Swaroop Bose, Mashkura Chowdhury, Avner Shemer, Ana B. Pavel, Emma Guttman-Yassky. Allergy: European Journal of Allergy and Clinical Immunology

Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin. Madeline Kim, Ester Del Duca, Julia Cheng, Britta Carroll, Paola Facheris, Yeriel Estrada, Amy Cha, John Werth, Robert Bissonnette, Karl Nocka, Chuanbo Zang, Ana B. Pavel, Emma Guttman-Yassky. Journal of the American Academy of Dermatology

Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort. Katrina Abuabara, Lawrence F. Eichenfield, Robert Bissonnette, Jonathan I. Silverberg, Jerry Bagel, Emma Guttman-Yassky, Diamant Thaci, Eric L. Simpson, John E. Harris, James Krueger, Daniela E. Myers, Amy Gamelli, Marina Milutinovic, Anne Parneix, Julie M. Crawford, Janet S. Hildebrand, Breda Munoz, Amy S. Paller. Journal of the American Academy of Dermatology

View All Publications

Annenberg Building Floor 11th

1468 Madison Ave

New York, NY 10029

Mount Sinai Doctors Floor 5th Room Dermatology Suite

5 E 98th St

New York, NY 10029

212-241-9728

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Guttman during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

  • Boston Pharmaceuticals
  • Schrodinger Inc
  • GlaxoSmithKline
  • Pfizer Inc.
  • Incyte Corporation
  • Q32 Bio
  • Eli Lilly and Company
  • RAPT Therapeutics
  • sanofi-aventis
  • Cara Therapeutics
  • SATO Pharmaceuticals
  • Bluefin
  • Evommune Inc
  • Almirall, S.A.
  • Galderma S.A.
  • Amgen Inc.
  • Bristol-Myers Squibb
  • Escient Pharmaceuticals
  • Allergan, Inc. / MAP Pharmaceuticals, Inc. collaboration
  • Kyowa Kirin Co., Ltd.
  • ribon therapeutics
  • AbbVie Inc.
  • Aslan Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Janssen Pharmaceuticals, Inc.
  • Genzyme Corporation
  • LEO Pharma A/S
  • connect Biopharma
  • AnaptysBio
  • Arcutis Biotherapeutics

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.